Literature DB >> 20600021

Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.

Philippe Podevin1, Arnaud Carpentier, Véronique Pène, Lynda Aoudjehane, Matthieu Carrière, Sakina Zaïdi, Céline Hernandez, Vanessa Calle, Jean-François Méritet, Olivier Scatton, Marlène Dreux, François-Loïc Cosset, Takaji Wakita, Ralf Bartenschlager, Sylvie Demignot, Filoména Conti, Arielle R Rosenberg, Yvon Calmus.   

Abstract

BACKGROUND & AIMS: Although hepatitis C virus (HCV) can be grown in the hepatocarcinoma-derived cell line Huh-7, a cell-culture model is needed that supports its complete, productive infection cycle in normal, quiescent, highly differentiated human hepatocytes. We sought to develop such a system.
METHODS: Primary cultures of human adult hepatocytes were inoculated with HCV derived from Huh-7 cell culture (HCVcc) and monitored for expression of hepatocyte differentiation markers and replication of HCV. Culture supernatants were assayed for HCV RNA, core antigen, and infectivity titer. The buoyant densities of input and progeny virus were compared in iodixanol gradients.
RESULTS: While retaining expression of differentiation markers, primary hepatocytes supported the complete infectious cycle of HCV, including production of significant titers of new infectious progeny virus, which was called primary-culture-derived virus (HCVpc). Compared with HCVcc, HCVpc had lower average buoyant density and higher specific infectivity; this was similar to the characteristics of virus particles associated with the very-low-density lipoproteins that are produced during in vivo infection. These properties were lost after re-culture of HCVpc in poorly differentiated Huh-7 cells, suggesting that authentic virions can be produced only by normal hepatocytes that secrete authentic very-low-density lipoproteins.
CONCLUSIONS: We have established a cell-culture-based system that allows production of infectious HCV in physiologically relevant human hepatocytes. This provides a useful tool for the study of HCV interactions with its natural host cell and for the development of antiviral therapies.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20600021     DOI: 10.1053/j.gastro.2010.06.058

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  69 in total

1.  Humanized murine model for HBV and HCV using human induced pluripotent stem cells.

Authors:  Xiao-Ling Zhou; Gareth J Sullivan; Pingnan Sun; In-Hyun Park
Journal:  Arch Pharm Res       Date:  2012-02-28       Impact factor: 4.946

2.  Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Authors:  Maria V Pokrovskii; Caroline O Bush; Rudolf K F Beran; Margaret F Robinson; Guofeng Cheng; Neeraj Tirunagari; Martijn Fenaux; Andrew E Greenstein; Weidong Zhong; William E Delaney; Matthew S Paulson
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 3.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

4.  Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Authors:  Kathrin Hueging; Mandy Doepke; Gabrielle Vieyres; Dorothea Bankwitz; Anne Frentzen; Juliane Doerrbecker; Frauke Gumz; Sibylle Haid; Benno Wölk; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.

Authors:  Ignacio Benedicto; Francisca Molina-Jiménez; Ricardo Moreno-Otero; Manuel López-Cabrera; Pedro L Majano
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 6.  The ins and outs of hepatitis C virus entry and assembly.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

7.  The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles.

Authors:  Audrey Boyer; Amélie Dumans; Elodie Beaumont; Loïc Etienne; Philippe Roingeard; Jean-Christophe Meunier
Journal:  J Biol Chem       Date:  2014-05-16       Impact factor: 5.157

8.  Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.

Authors:  Thibaut Vausselin; Karin Séron; Muriel Lavie; Ahmed Atef Mesalam; Matthieu Lemasson; Sandrine Belouzard; Lucie Fénéant; Adeline Danneels; Yves Rouillé; Laurence Cocquerel; Lander Foquet; Arielle R Rosenberg; Czeslaw Wychowski; Philip Meuleman; Patricia Melnyk; Jean Dubuisson
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.

Authors:  Andreas Merz; Gang Long; Marie-Sophie Hiet; Britta Brügger; Petr Chlanda; Patrice Andre; Felix Wieland; Jacomine Krijnse-Locker; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

10.  Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.

Authors:  Lisa N Wasilewski; Stuart C Ray; Justin R Bailey
Journal:  J Gen Virol       Date:  2016-09-21       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.